Takeo Urakami

1.5k total citations
21 papers, 1.2k citations indexed

About

Takeo Urakami is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Takeo Urakami has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Biomaterials and 6 papers in Biomedical Engineering. Recurrent topics in Takeo Urakami's work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Nonlinear Optical Materials Studies (3 papers). Takeo Urakami is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Nonlinear Optical Materials Studies (3 papers). Takeo Urakami collaborates with scholars based in Japan, United States and Finland. Takeo Urakami's co-authors include Naoto Oku, Hiroyuki Koide, Yu Hoshino, Kenneth J. Shea, Takashi Kodama, Hiroaki Kanazawa, Masanobu Komatsu, Tomohiro Asai, Kevin D. Belfield and Alma R. Morales and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takeo Urakami

21 papers receiving 1.2k citations

Peers

Takeo Urakami

BIOMA

Chrysafis Andreou United States

Bin Du China

Daniela Fraier United Kingdom

Xiaoqing Yi China

Weijie Qin China

Lulu Ning China

Minghuang Hong China

Sidan Tian China

Yuna Guo China

Chrysafis Andreou United States

Takeo Urakami

577 ×1.2

937 ×2.3

112 ×0.4

202 ×0.7

BIOMA

270 ×1.3

Citations per year, relative to Takeo Urakami Takeo Urakami (= 1×) peers Chrysafis Andreou

Countries citing papers authored by Takeo Urakami

Since Specialization

Citations

This map shows the geographic impact of Takeo Urakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Urakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Urakami more than expected).

Fields of papers citing papers by Takeo Urakami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Urakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Urakami. The network helps show where Takeo Urakami may publish in the future.

Co-authorship network of co-authors of Takeo Urakami

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Urakami. A scholar is included among the top collaborators of Takeo Urakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Urakami. Takeo Urakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakamura, Yuki, Takeo Urakami, Kayoko Ishimaru, et al.. (2024). A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation. SHILAP Revista de lepidopterología. 3(3). 100249–100249. 5 indexed citations

Urakami, Takeo, Takafumi Shimizu, William Sinko, et al.. (2023). Identification of MOD000001, A Novel Highly Selective and Orally Available KIT Inhibitor Designed for Treatment of Mast Cell-Associated Disorders. Journal of Allergy and Clinical Immunology. 151(2). AB204–AB204. 2 indexed citations

Shimizu, Kosuke, et al.. (2016). Specific delivery of an immunosuppressive drug to splenic B cells by antigen-modified liposomes and its antiallergic effect. Journal of drug targeting. 24(9). 890–895. 5 indexed citations

Toba, Michie, Abdallah Alzoubi, Kohtaro Abe, et al.. (2014). A Novel Vascular Homing Peptide Strategy to Selectively Enhance Pulmonary Drug Efficacy in Pulmonary Arterial Hypertension. American Journal Of Pathology. 184(2). 369–375. 42 indexed citations

Ichikawa, Kanae, Tomohiro Asai, Kosuke Shimizu, et al.. (2013). Suppression of immune response by antigen-modified liposomes encapsulating model agents: A novel strategy for the treatment of allergy. Journal of Controlled Release. 167(3). 284–289. 14 indexed citations

Yanez, Ciceron O., Alma R. Morales, Xiling Yue, et al.. (2013). Deep Vascular Imaging in Wounds by Two-Photon Fluorescence Microscopy. PLoS ONE. 8(7). e67559–e67559. 24 indexed citations

Morales, Alma R., Ciceron O. Yanez, Yuanwei Zhang, et al.. (2012). Small molecule fluorophore and copolymer RGD peptide conjugates for ex vivo two-photon fluorescence tumor vasculature imaging. Biomaterials. 33(33). 8477–8485. 32 indexed citations

Sawada, Junko, Takeo Urakami, Fangfei Li, et al.. (2012). Small GTPase R-Ras Regulates Integrity and Functionality of Tumor Blood Vessels. Cancer Cell. 22(2). 235–249. 88 indexed citations

Urakami, Takeo, Tero A.H. Järvinen, Michie Toba, et al.. (2011). Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension. American Journal Of Pathology. 178(6). 2489–2495. 40 indexed citations

10.

Andrade, Carolina D., Ciceron O. Yanez, Hyo-Yang Ahn, et al.. (2011). Two-Photon Fluorescence Vascular Bioimaging with New Bioconjugate Probes Selective toward the Vascular Endothelial Growth Factor Receptor 2. Bioconjugate Chemistry. 22(10). 2060–2071. 18 indexed citations

11.

Wang, Xuhua, Alma R. Morales, Takeo Urakami, Masanobu Komatsu, & Kevin D. Belfield. (2011). Folate Receptor-targeted Aggregation-enhanced Emission Silica Nanoprobe for One-photon in vivo and Two-photon ex vivo Fluorescence Bioimaging. Journal of International Crisis and Risk Communication Research. OMD3–OMD3. 1 indexed citations

12.

Wang, Xuhua, Alma R. Morales, Takeo Urakami, et al.. (2011). Folate Receptor-Targeted Aggregation-Enhanced Near-IR Emitting Silica Nanoprobe for One-Photon in Vivo and Two-Photon ex Vivo Fluorescence Bioimaging. Bioconjugate Chemistry. 22(7). 1438–1450. 101 indexed citations

13.

Ishii, Takayuki, Tomohiro Asai, Takeo Urakami, & Naoto Oku. (2010). Accumulation of macromolecules in brain parenchyma in acute phase of cerebral infarction/reperfusion. Brain Research. 1321. 164–168. 23 indexed citations

14.

Oku, Naoto, Takeo Urakami, Kentaro Hatanaka, et al.. (2010). PET imaging of brain cancer with positron emitter-labeled liposomes. International Journal of Pharmaceutics. 403(1-2). 170–177. 45 indexed citations

15.

Hoshino, Yu, Hiroyuki Koide, Takeo Urakami, et al.. (2010). Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody. Journal of the American Chemical Society. 132(19). 6644–6645. 413 indexed citations

16.

Urakami, Takeo, et al.. (2009). Evaluation of O-[18F]fluoromethyl-d-tyrosine as a radiotracer for tumor imaging with positron emission tomography. Nuclear Medicine and Biology. 36(3). 295–303. 30 indexed citations

17.

Hoshino, Yu, Takeo Urakami, Takashi Kodama, et al.. (2009). Design of Synthetic Polymer Nanoparticles that Capture and Neutralize a Toxic Peptide. Small. 5(13). 1562–1568. 92 indexed citations

18.

Urakami, Takeo, Akira T. Kawaguchi, Shuji Akai, et al.. (2009). In Vivo Distribution of Liposome‐Encapsulated Hemoglobin Determined by Positron Emission Tomography. Artificial Organs. 33(2). 164–168. 38 indexed citations

19.

Koide, Hiroyuki, Tomohiro Asai, Kentaro Hatanaka, et al.. (2008). Particle size-dependent triggering of accelerated blood clearance phenomenon. International Journal of Pharmaceutics. 362(1-2). 197–200. 126 indexed citations

20.

Urakami, Takeo, et al.. (2007). Novel Amphiphilic Probes for [¹⁸F]-Radiolabeling Preformed Liposomes and Determination of Liposomal Trafficking by Positron Emission Tomography. Journal of Medicinal Chemistry. 50(26). 6454–6457. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact